Amphastar Pharmaceuticals Inc at Needham Healthcare Conference Transcript
This is Serge Belanger from Needham and Company. Welcome to the 19th annual Needham healthcare conference. Apologies for the delay. We had some technical difficulties. So for the next 30 minutes, we will be talking with the Amphastar Pharmaceuticals team. We have Bill Peters, the Company's CFO. We have Dan Dischner, the VP of corporate communications, as well as Tony Marrs of regulatory affairs.
So gentlemen, welcome, and if you wouldn't mind with starting with a brief corporate update on the Company.
Yes, thanks, Serge. This is Bill. I am going to turn the call over to Dan for a brief update.
Okay. Thanks, Bill. I'm going to address the impact -- I think a lot of people are curious on the impact of COVID-19. I will start with addressing that. The Company has several talented, dedicated people who have pulled
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
